Sonic Healthcare Limited (AU:SHL)
ASX:SHL
Want to see AU:SHL full AI Analyst Report?
SHL Stock Chart & Stats
AU$20.56
-AU$0.19(-0.67%)
At close: 4:00 PM EST
AU$20.56
-AU$0.19(-0.67%)
Day’s Range― - ―
52-Week RangeAU$18.26 - AU$29.24
Previous CloseN/A
Volume607.50K
Average Volume (3M)1.62M
Market Cap
AU$9.23B
Enterprise ValueAU$16.58B
Total Cash (Recent Filing)AU$557.12M
Total Debt (Recent Filing)AU$7.34B
Price to Earnings (P/E)10.6
Beta0.73
Next Earnings
Aug 20, 2026EPS Estimate
0.66Next Dividend Ex-DateN/A
Dividend Yield4.69%
Share Statistics
EPS (TTM)1.11
Shares Outstanding494,237,950
10 Day Avg. Volume1,694,025
30 Day Avg. Volume1,619,425
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.55
Price to Sales (P/S)1.34
P/FCF Ratio13.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$22.09Price Target Upside7.44% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)1.22
Revenue Forecast (FY)AU$10.95B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationSonic's FCF growth (+16.63%) and OCF-to-net-income of 2.53 show durable cash conversion from operations. That persistent cash generation supports the progressive dividend policy, funds capex/automation, and creates headroom for debt repayment or strategic buybacks without relying on external funding.
Diversified Global Diagnostic PlatformSonic's exposure across pathology, imaging and multiple geographies spreads payer and policy risk. Consistent ~5% organic growth, with regional outperformance in Germany, Australia and the UK, indicates structural demand resilience from ageing populations, contracted hospital work and national screening programs.
Margin Expansion Via Scale And ProductivityMargin improvement driven by hub labs, procurement savings, automation and integration of recent acquisitions is structural: platform consolidation and process automation reduce per-test costs over time, supporting sustainable EBITDA margin expansion as volumes normalize and synergies are captured.
Bears Say
Higher Leverage From Acquisitions & Property SpendRising leverage from LADR and property purchases reduces financial flexibility. Higher net debt increases interest sensitivity (management forecasts ~15% higher interest expense), constrains payout and M&A optionality, and raises refinance risk if rates or cash generation weaken.
U.S. Margin Pressure And RestructuringThe U.S. business faces structural profitability headwinds: low organic growth, sizable AP exposure (~$400m of ~$1.4bn) and active practice rationalisation will weigh on near-term margins and create execution risk as Sonic restructures networks and seeks to restore U.S. operating leverage.
Working-capital Disruption From Third-party Cyber IncidentBilling/collection disruption from the Change Healthcare cyber incident has materially distorted receivables and working capital, increasing net debt and reducing free cash flow visibility. Slow normalization can persist, delaying cash benefits and stressing liquidity even after operational recovery.
Sonic Healthcare Limited News
SHL FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Sonic Healthcare Limited lowest share price was AU$18.26 and its highest was AU$29.24 in the past 12 months.
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is AU$9.23B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Aug 20, 2026 which is in 88 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Feb 18, 2026. The company reported AU$0.5 earnings per share for the quarter, missing the consensus estimate of AU$0.527 by -AU$0.027.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Undervalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited pays a Semiannually dividend of AU$0.63 which represents an annual dividend yield of 4.69%. See more information on Sonic Healthcare Limited dividends here
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.66.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of AU$0.5 in its last earnings report, missing expectations of AU$0.527. Following the earnings report the stock price went up 9.887%.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in AU:SHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$22.09 (7.44% Upside)
AU$22.09 (7.44% Upside)
Blogger Sentiment
Bullish
AU:SHL Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.99%
12-Months-Change
Fundamentals
Return on Equity
6.39%
Trailing 12-Months
Asset Growth
10.74%
Trailing 12-Months
Company Description
Sonic Healthcare Limited
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
SHL Stock 12 Month Forecast
Average Price Target
AU$22.09
▲(7.44% Upside)
Technical Analysis
Healius Limited
―
Genetic Signatures Ltd.
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Monash IVF Group Ltd
―
Options Prices
Currently, No data available
---